Analysts Set Neumora Therapeutics, Inc. (NASDAQ:NMRA) PT at $9.29
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) has received an average rating of “Hold” from the nine analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and three have issued a buy recommendation on the company. […]
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) has received an average rating of “Hold” from the nine analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and three have issued a buy recommendation on the company. […]
